Randomized Controlled Trial
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 7, 2014; 20(29): 10151-10157
Published online Aug 7, 2014. doi: 10.3748/wjg.v20.i29.10151
Table 1 Comparison of the two groups of patients according to patient and investigation characteristics (n = 665) n (%)
Patient and investigation characteristicsIndomethacin group(n = 347)Control group(n = 318)
Gender
Male (n = 239)133 (55.64)106 (44.35)
Female (n = 426)214 (50.23)212 (49.76)
Age
< 70 yr (n = 355)190 (53.52)165 (46.48)
> 70 yr (n = 310)157 (50.65)153 (49.35)
BMI
< 25 (n = 303)156 (51.48)147 (48.51)
25-30 (n = 236)125 (53.96)111 (47.03)
> 30 (n = 126)66 (52.38)60 (47.62)
Duration of ERCP
< 20 min (n = 454)236 (52.0)218 (48.0)
> 20 min (n = 211)111 (52.6)100 (47.4)
Dilated/non-dilated bile duct
Dilated (n = 366)189 (51.64)177 (48.36)
Non-dilated (n = 299)158 (52.84)141 (47.15)
Pancreatic duct opacification (n = 463)246 (53.13)217 (46.87)
EST
Biliary (n = 443)224 (50.56)219 (49.43)
Pancreatic/double (n = 48)22 (44.0)28 (56.0)
Difficult cannulation (n = 116)64 (55.17)52 (44.83)
Gallstone extraction (n = 165)82 (49.7)83 (50.3)
Bile duct dilatation (n = 22)11 (50.0)11 (50.0)
Biliary stent placement
Plastic stent (n = 75)35 (46.7)40 (53.3)
Metal stent00